CN Stock MarketDetailed Quotes
300888 Winner Medical
- 41.50
- +1.12+2.77%
Market Closed Dec 12 15:00 CST
24.17BMarket Cap-23.82P/E (TTM)
41.90High39.64Low99.03KlotVolume39.80Open40.38Pre Close407.80MTurnover5.64%Turnover Ratio41.62P/E (Static)582.33MShares41.9052wk High2.15P/B7.28BFloat Cap22.9152wk Low48.46Limit Up175.51MShs Float151.96Historical High32.30Limit Down5.60%Amplitude22.91Historical Low0.90Dividend TTM41.18Avg Price44.82KlotAsk2.17%Div YieldTTM100Lot Size47.96KlotBid
Winner Medical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.99%6.07B | -5.47%4.03B | -18.84%1.91B | -27.89%8.19B | -21.35%6.01B | -17.28%4.27B | 1.28%2.35B | 41.23%11.35B | 31.31%7.64B | 27.05%5.16B |
| Operating revenue | 0.99%6.07B | -5.47%4.03B | -18.84%1.91B | -27.89%8.19B | -21.35%6.01B | -17.28%4.27B | 1.28%2.35B | 41.23%11.35B | 31.31%7.64B | 27.05%5.16B |
| Other operating revenue | ---- | 7.71%33.14M | ---- | -35.14%60.7M | ---- | -30.18%30.77M | ---- | 52.91%93.58M | ---- | -1.22%44.07M |
| Total operating cost | 6.20%5.43B | 2.15%3.58B | -9.45%1.71B | -20.11%7.29B | -17.35%5.11B | -15.08%3.5B | -0.87%1.89B | 35.55%9.12B | 31.46%6.19B | 26.11%4.12B |
| Operating cost | 5.11%3.15B | -0.14%2.07B | -13.31%999.87M | -30.11%4.17B | -24.82%2.99B | -21.55%2.07B | -4.91%1.15B | 48.27%5.97B | 34.34%3.98B | 37.40%2.64B |
| Operating tax surcharges | 3.73%51.87M | -1.85%36.66M | -15.29%16.31M | -32.29%66.41M | -22.81%50.01M | -9.26%37.35M | 4.81%19.26M | 50.00%98.09M | 48.93%64.79M | 24.14%41.16M |
| Operating expense | 9.02%1.58B | 9.92%1.06B | 1.60%477.84M | 1.97%2.09B | 3.25%1.45B | 1.08%960.44M | 0.11%470.32M | 3.07%2.05B | 13.16%1.4B | 15.06%950.17M |
| Administration expense | 8.68%467.74M | 6.85%309.45M | 2.05%151.79M | 9.47%693.65M | -10.19%430.38M | -11.00%289.6M | 16.19%148.75M | 39.44%633.61M | 108.11%479.21M | 4.74%325.39M |
| Financial expense | 41.11%-45.41M | 29.08%-37.44M | 16.82%-14.6M | 49.53%-61.86M | 33.94%-77.1M | 28.29%-52.79M | 18.59%-17.55M | -14.02%-122.57M | -172.85%-116.71M | -483.52%-73.62M |
| -Interest expense (Financial expense) | -22.18%37.66M | -26.99%24.02M | -27.71%11.26M | 26.77%63.44M | 44.30%48.4M | 72.03%32.89M | 107.22%15.57M | 66.87%50.04M | 8,258.02%33.54M | 4,935.20%19.12M |
| -Interest Income (Financial expense) | 17.53%-89.71M | 18.39%-57.01M | 28.89%-23.58M | -8.07%-133.91M | -20.51%-108.79M | -12.52%-69.86M | -13.54%-33.17M | 9.68%-123.91M | -62.28%-90.27M | -75.27%-62.09M |
| Research and development | -13.84%231.68M | -26.46%143.14M | -31.64%76M | -33.95%322.05M | -28.19%268.9M | -18.44%194.64M | 17.76%111.18M | 63.53%487.58M | 37.85%374.44M | 25.66%238.64M |
| Credit Impairment Loss | -3,853.84%-7.57M | -392.93%-8.3M | -317.84%-5.05M | 107.39%4.73M | -92.38%201.63K | 136.55%2.83M | 126.56%2.32M | -11,039.94%-63.94M | -81.21%2.64M | -165.62%-7.75M |
| Asset Impairment Loss | 59.79%-59.28M | 44.47%-55.98M | 81.32%-17.75M | -8.51%-393.76M | -26.62%-147.43M | -37.99%-100.79M | -254.14%-94.99M | -260.47%-362.87M | -126.46%-116.44M | -20.54%-73.05M |
| Other net revenue | -97.40%43.12M | -69.93%15.97M | 273.35%24.47M | 67.97%-81.71M | 6,011.54%1.66B | 278.17%53.09M | -490.79%-14.12M | -253.60%-255.09M | -83.26%27.16M | -88.24%14.04M |
| Fair value change income | -95.40%2.74M | -87.29%7.58M | -68.72%14.43M | 45.19%46.68M | 32.57%59.58M | 69.52%59.64M | 178.75%46.13M | -45.02%32.15M | 20.51%44.94M | 12.02%35.18M |
| Invest income | -28.58%54.17M | -15.14%33.45M | 17.09%14.69M | 147.41%127.34M | 70.72%75.84M | 25.31%39.41M | 29.75%12.54M | -50.14%51.47M | -35.29%44.43M | -37.19%31.45M |
| -Including: Investment income associates | -2,338.09%-11.67M | -585.14%-7.67M | -93.53%60.78K | -66.33%1.58M | -83.15%521.52K | -34.36%1.58M | -21.59%939.81K | 33.25%4.7M | 16.66%3.1M | 45.46%2.41M |
| Asset deal income | -99.83%2.76M | -63.74%1.93M | --797.54K | 764.20%32.2M | 199,369.84%1.6B | 1,073.21%5.32M | --0 | 14.64%3.73M | -1,752.53%-803.86K | -1,354.32%-547.13K |
| Other revenue | -27.79%50.29M | -20.13%37.28M | -12.70%17.35M | 19.83%101.11M | 32.94%69.65M | 62.38%46.68M | 49.66%19.88M | -17.57%84.37M | -44.07%52.39M | -66.86%28.75M |
| Operating profit | -73.28%683.47M | -42.21%473.46M | -50.02%226.27M | -58.62%817.97M | 72.36%2.56B | -21.95%819.28M | 6.76%452.71M | 33.95%1.98B | 16.21%1.48B | 15.28%1.05B |
| Add:Non operating Income | -20.53%6.98M | -8.34%6.14M | 22.74%2.25M | 57.23%16.62M | 114.05%8.78M | 211.32%6.7M | 46.62%1.84M | 74.99%10.57M | 5.88%4.1M | -7.97%2.15M |
| Less:Non operating expense | -25.17%7.86M | 26.72%6.22M | 245.79%4.77M | 25.33%84.74M | -38.31%10.5M | -43.17%4.91M | -72.11%1.38M | 257.38%67.61M | 14.13%17.02M | 1.54%8.63M |
| Total profit | -73.29%682.59M | -42.35%473.38M | -50.62%223.76M | -60.94%749.85M | 73.75%2.56B | -21.29%821.07M | 7.81%453.16M | 31.22%1.92B | 16.20%1.47B | 15.35%1.04B |
| Less:Income tax cost | -73.94%96.39M | -41.55%67.15M | -53.62%30.25M | -50.52%121.3M | 81.20%369.81M | -21.13%114.89M | 3.88%65.22M | 8.81%245.17M | 26.18%204.09M | 1.66%145.67M |
| Net profit | -73.18%586.19M | -42.48%406.23M | -50.12%193.51M | -62.46%628.55M | 72.56%2.19B | -21.32%706.19M | 8.49%387.94M | 35.31%1.67B | 14.74%1.27B | 17.92%897.53M |
| Net profit from continuing operation | -73.18%586.19M | -42.48%406.23M | -50.12%193.51M | -62.46%628.55M | 72.56%2.19B | -21.32%706.19M | 8.49%387.94M | 35.31%1.67B | 14.74%1.27B | 17.92%897.53M |
| Less:Minority Profit | -12.92%33.23M | -10.13%22.08M | 0.78%11.09M | 103.82%48.14M | 131.15%38.16M | 422.25%24.57M | 2,263.69%11M | 1,359.61%23.62M | 409,257.81%16.51M | 5,693.17%4.7M |
| Net profit of parent company owners | -74.25%552.97M | -43.64%384.15M | -51.60%182.42M | -64.84%580.4M | 71.78%2.15B | -23.66%681.62M | 5.56%376.94M | 33.20%1.65B | 13.25%1.25B | 17.32%892.82M |
| Earning per share | ||||||||||
| Basic earning per share | -73.97%0.95 | -43.37%0.6568 | -51.56%0.31 | -64.87%0.98 | 72.17%3.65 | -23.73%1.1599 | -23.81%0.64 | -4.12%2.79 | -18.15%2.12 | -14.78%1.5207 |
| Diluted earning per share | -73.97%0.95 | -43.37%0.6568 | -51.56%0.31 | -64.87%0.98 | 72.17%3.65 | -23.73%1.1599 | -23.81%0.64 | -4.12%2.79 | -17.51%2.12 | -14.16%1.5207 |
| Other composite income | -927.19%-15.87M | -303.05%-5.38M | 241.81%1.03M | -26.04%2.62M | -43.09%1.92M | 81.82%2.65M | -221.81%-725.53K | 527.04%3.55M | 1,346.21%3.37M | 598.31%1.46M |
| Other composite income of parent company owners | -861.29%-8.9M | -287.45%-2.93M | 243.70%599.56K | -38.77%1.43M | -41.91%1.17M | 78.90%1.56M | -232.11%-417.23K | 624.72%2.34M | 1,733.32%2.01M | 723.87%874.16K |
| Other composite income of minority owners | -1,029.88%-6.98M | -325.49%-2.45M | 239.25%429.32K | -1.37%1.19M | -44.83%750.1K | 86.19%1.09M | -208.85%-308.3K | 413.86%1.21M | 1,022.64%1.36M | 482.88%583.6K |
| Total composite income | -73.93%570.32M | -43.45%400.85M | -49.76%194.54M | -62.38%631.17M | 72.25%2.19B | -21.15%708.84M | 8.36%387.22M | 35.68%1.68B | 15.08%1.27B | 18.16%898.99M |
| Total composite income of parent company owners | -74.68%544.07M | -44.20%381.22M | -51.39%183.02M | -64.80%581.84M | 71.60%2.15B | -23.56%683.18M | 5.48%376.52M | 33.43%1.65B | 13.44%1.25B | 17.45%893.7M |
| Total composite income of minority owners | -32.53%26.25M | -23.49%19.63M | 7.70%11.52M | 98.70%49.33M | 117.75%38.91M | 385.17%25.66M | 2,824.66%10.69M | 1,198.58%24.83M | 12,565.79%17.87M | 7,525.32%5.29M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
